Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins

Katarzyna Niemirowicz,1 Ewelina Piktel,1 Agnieszka Z Wilczewska,2 Karolina H Markiewicz,2 Bonita Durnaś,3 Marzena Wątek,4 Irena Puszkarz,3 Marta Wróblewska,5,6 Wieslawa Niklińska,7 Paul B Savage,8 Robert Bucki1,3 1Department of Microbiological and Nanobiomedical Engineering, Medical Univ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Niemirowicz K, Piktel E, Wilczewska AZ, Markiewicz KH, Durnaś B, Wątek M, Puszkarz I, Wróblewska M, Niklińska W, Savage PB, Bucki R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/9f1d9cf600ce49c79f8263dcffacd3a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f1d9cf600ce49c79f8263dcffacd3a1
record_format dspace
spelling oai:doaj.org-article:9f1d9cf600ce49c79f8263dcffacd3a12021-12-02T01:55:20ZCore–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins1178-2013https://doaj.org/article/9f1d9cf600ce49c79f8263dcffacd3a12016-10-01T00:00:00Zhttps://www.dovepress.com/corendashshell-magnetic-nanoparticles-display-synergistic-antibacteria-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Katarzyna Niemirowicz,1 Ewelina Piktel,1 Agnieszka Z Wilczewska,2 Karolina H Markiewicz,2 Bonita Durnaś,3 Marzena Wątek,4 Irena Puszkarz,3 Marta Wróblewska,5,6 Wieslawa Niklińska,7 Paul B Savage,8 Robert Bucki1,3 1Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, 2Institute of Chemistry, University of Bialystok, Bialystok, 3Department of Physiology, Pathophysiology and Immunology of Infections, The Faculty of Health Sciences of the Jan Kochanowski University in Kielce, 4Holy Cross Oncology Center of Kielce, Kielce, 5Department of Dental Microbiology, Medical University of Warsaw, 6Department of Microbiology, Central Clinical Hospital in Warsaw, Warsaw, 7Department of Histology and Embryology, Medical University of Bialystok, Bialystok, Poland; 8Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA Abstract: Core–shell magnetic nanoparticles (MNPs) are promising candidates in the development of new treatment methods against infections, including those caused by antibiotic-resistant pathogens. In this study, the bactericidal activity of human antibacterial peptide cathelicidin LL-37, synthetic ceragenins CSA-13 and CSA-131, and classical antibiotics vancomycin and colistin, against methicillin-resistant Staphylococcus aureus Xen 30 and Pseudomonas aeruginosa Xen 5, was assessed alone and in combination with core–shell MNPs. Fractional inhibitory concentration index and fractional bactericidal concentration index were determined by microdilution methods. The potential of combined therapy using nanomaterials and selected antibiotics was confirmed using chemiluminescence measurements. Additionally, the ability of tested agents to prevent bacterial biofilm formation was evaluated using crystal violet staining. In most conditions, synergistic or additive effects were observed when combinations of core–shell MNPs with ceragenins or classical antibiotics were used. Our study revealed that a mixture of membrane-active agents such as LL-37 peptide or ceragenin CSA-13 with MNPs potentialized their antibacterial properties and might be considered as a method of delaying and overcoming bacterial drug resistance. Keywords: synergistic activity, antibiotic-resistant bacteria, LL-37 peptide, ceragenins, magnetic nanoparticlesNiemirowicz KPiktel EWilczewska AZMarkiewicz KHDurnaś BWątek MPuszkarz IWróblewska MNiklińska WSavage PBBucki RDove Medical Pressarticlesynergistic activityantibiotic resistant bacteriaLL-37 peptidecerageninsmagnetic nanoparticlesMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 5443-5455 (2016)
institution DOAJ
collection DOAJ
language EN
topic synergistic activity
antibiotic resistant bacteria
LL-37 peptide
ceragenins
magnetic nanoparticles
Medicine (General)
R5-920
spellingShingle synergistic activity
antibiotic resistant bacteria
LL-37 peptide
ceragenins
magnetic nanoparticles
Medicine (General)
R5-920
Niemirowicz K
Piktel E
Wilczewska AZ
Markiewicz KH
Durnaś B
Wątek M
Puszkarz I
Wróblewska M
Niklińska W
Savage PB
Bucki R
Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
description Katarzyna Niemirowicz,1 Ewelina Piktel,1 Agnieszka Z Wilczewska,2 Karolina H Markiewicz,2 Bonita Durnaś,3 Marzena Wątek,4 Irena Puszkarz,3 Marta Wróblewska,5,6 Wieslawa Niklińska,7 Paul B Savage,8 Robert Bucki1,3 1Department of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, 2Institute of Chemistry, University of Bialystok, Bialystok, 3Department of Physiology, Pathophysiology and Immunology of Infections, The Faculty of Health Sciences of the Jan Kochanowski University in Kielce, 4Holy Cross Oncology Center of Kielce, Kielce, 5Department of Dental Microbiology, Medical University of Warsaw, 6Department of Microbiology, Central Clinical Hospital in Warsaw, Warsaw, 7Department of Histology and Embryology, Medical University of Bialystok, Bialystok, Poland; 8Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA Abstract: Core–shell magnetic nanoparticles (MNPs) are promising candidates in the development of new treatment methods against infections, including those caused by antibiotic-resistant pathogens. In this study, the bactericidal activity of human antibacterial peptide cathelicidin LL-37, synthetic ceragenins CSA-13 and CSA-131, and classical antibiotics vancomycin and colistin, against methicillin-resistant Staphylococcus aureus Xen 30 and Pseudomonas aeruginosa Xen 5, was assessed alone and in combination with core–shell MNPs. Fractional inhibitory concentration index and fractional bactericidal concentration index were determined by microdilution methods. The potential of combined therapy using nanomaterials and selected antibiotics was confirmed using chemiluminescence measurements. Additionally, the ability of tested agents to prevent bacterial biofilm formation was evaluated using crystal violet staining. In most conditions, synergistic or additive effects were observed when combinations of core–shell MNPs with ceragenins or classical antibiotics were used. Our study revealed that a mixture of membrane-active agents such as LL-37 peptide or ceragenin CSA-13 with MNPs potentialized their antibacterial properties and might be considered as a method of delaying and overcoming bacterial drug resistance. Keywords: synergistic activity, antibiotic-resistant bacteria, LL-37 peptide, ceragenins, magnetic nanoparticles
format article
author Niemirowicz K
Piktel E
Wilczewska AZ
Markiewicz KH
Durnaś B
Wątek M
Puszkarz I
Wróblewska M
Niklińska W
Savage PB
Bucki R
author_facet Niemirowicz K
Piktel E
Wilczewska AZ
Markiewicz KH
Durnaś B
Wątek M
Puszkarz I
Wróblewska M
Niklińska W
Savage PB
Bucki R
author_sort Niemirowicz K
title Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
title_short Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
title_full Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
title_fullStr Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
title_full_unstemmed Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
title_sort core–shell magnetic nanoparticles display synergistic antibacterial effects against pseudomonas aeruginosa and staphylococcus aureus when combined with cathelicidin ll-37 or selected ceragenins
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/9f1d9cf600ce49c79f8263dcffacd3a1
work_keys_str_mv AT niemirowiczk corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT piktele corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT wilczewskaaz corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT markiewiczkh corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT durnasb corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT watekm corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT puszkarzi corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT wroblewskam corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT niklinskaw corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT savagepb corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
AT buckir corendashshellmagneticnanoparticlesdisplaysynergisticantibacterialeffectsagainstpseudomonasaeruginosaandstaphylococcusaureuswhencombinedwithcathelicidinll37orselectedceragenins
_version_ 1718402793119678464